BCI
IDXX icon

Brinker Capital Investments’s Idexx Laboratories IDXX Stock Holding History

Brinker Capital Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1M Sell
7,782
-674
-8% -$378K 0.03% 460
2026
Q1 		$4.75M Sell
8,456
-1,785
-17% -$1.14M 0.04% 383
2025
Q4 		$6.93M Sell
10,241
-279
-3% -$190K 0.05% 327
2025
Q3 		$6.72M Sell
10,520
-198
-2% -$120K 0.05% 331
2025
Q2 		$5.75M Buy
10,718
+5,770
+117% +$2.76M 0.05% 351
2025
Q1 		$2.08M Buy
4,948
+893
+22% +$388K 0.02% 685
2024
Q4 		$1.68M Sell
4,055
-97
-2% -$42.5K 0.02% 782
2024
Q3 		$2.1M Buy
4,152
+584
+16% +$284K 0.02% 667
2024
Q2 		$1.74M Buy
3,568
+567
+19% +$285K 0.02% 712
2024
Q1 		$1.62M Buy
3,001
+91
+3% +$49.7K 0.02% 761
2023
Q4 		$1.58M Buy
2,910
+222
+8% +$104K 0.02% 744
2023
Q3 		$1.18M Buy
2,688
+81
+3% +$40.4K 0.01% 855
2023
Q2 		$8.31M Buy
2,607
+195
+8% +$93.4K 0.09% 226
2023
Q1 		$1.21M Buy
2,412
+1,264
+110% +$605K 0.01% 804
2022
Q4 		$468K Sell
1,148
-41
-3% -$15.9K 0.01% 1007
2022
Q3 		$387K Buy
1,189
+439
+59% +$161K 0.01% 1025
2022
Q2 		$263K Buy
750
+47
+7% +$19.2K 0.01% 1208
2022
Q1 		$385K Buy
703
+34
+5% +$17.9K 0.01% 1140
2021
Q4 		$441K Sell
669
-1,461
-69% -$917K 0.01% 1110
2021
Q3 		$1.34M Hold
2,130
– – 0.02% 669
2021
Q2 		$1.34M Buy
2,130
+109
+5% +$60.2K 0.02% 725
2021
Q1 		$989K Sell
2,021
-2,137
-51% -$1.07M 0.01% 709
2020
Q4 		$2.08M Buy
4,158
+2,061
+98% +$922K 0.03% 549
2020
Q3 		$824K Buy
+2,097
New +$775K 0.01% 747
2019
Q3 		– Sell
-330
Closed -$91K – 851
2019
Q2 		$91K Buy
330
+257
+352% +$63.3K ﹤0.01% 501
2019
Q1 		$16K Buy
+73
New +$15.1K ﹤0.01% 583
2013
Q4 		– Sell
-120
Closed -$6K – 398
2013
Q3 		$6K Hold
120
– – ﹤0.01% 346
2013
Q2 		$5K Buy
+120
New +$5.24K ﹤0.01% 337

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brinker Capital Investments's IDXX Position: Q2 2026 in Review

Brinker Capital Investments reduced its Idexx Laboratories (IDXX) stake by 8% in Q2 2026, selling an estimated $378K and leaving 7,782 shares worth $4.1M. The position accounts for 0.03% of the portfolio, ranked #460.

Brinker Capital Investments first reported a position in IDXX in Q2 2013 and has held it in 28 quarters since. The position peaked at $8.31M in Q2 2023. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Brinker Capital Investments held 7,782 shares of Idexx Laboratories worth $4.1M as of Q2 2026.
  • Brinker Capital Investments sold 674 Idexx Laboratories shares in Q2 2026, an estimated $378K.
  • Idexx Laboratories made up 0.03% of Brinker Capital Investments's portfolio in Q2 2026, its #460 holding.
  • Brinker Capital Investments first reported a position in Idexx Laboratories in Q2 2013 and has held it in 28 quarters since.
  • Brinker Capital Investments's Idexx Laboratories position peaked at $8.31M in Q2 2023.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.